Never Run Out Of Buyers To Sell To.

AMBROSIA BIO has developed a disruptive, evolutionary enzyme technology platform that is used to design superior enzymes to convert obesity-promoting industrial sugars into minimal-calorie rare sugars. AMBROSIA BIO’s B2B business model will provide the leading sugar & juice manufacturers the opportunity to meet customer expectations of sugar reduction without affecting the consumption experience. AMBROSIA BIO will deliver tailored (Plug and Play) engineering solutions for its partners to meet surging Allulose demand.
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.